Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
Health insurance claims are a growing headache for providers; many say their employers could do more to help them address the daily demands of insurers The post How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration appeared first on MedCity News.
A very small percentage of health outcomes are tied to direct healthcare activities. The non-medical factors, conditions in which people are born, grow, live, and work in, more often than not, impact health outcomes more than the clinical care they receive. The post A Reality Check on SDOH: Challenges We Can’t Ignore appeared first on…
[Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today! The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.
Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report. The post What Is the Economic Impact of Medicaid Work Requirements? appeared first on MedCity News.
Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023. The post J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test appeared first on MedCity News.
Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority. The post The Dementia Diagnosis Gap Is Wider Than We Think appeared first on MedCity News.
It’s time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management. The post Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs appeared first on MedCity News.
[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick. The post What Do Early Stage Life Science…
Like bandaids, AI chatbots can comfort us in times of desperation. But healing a wound takes more than a comforting bandaid. The post Are Therapy-Bots Really Our Best Chance At Solving Population Mental Health? appeared first on MedCity News.